Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ralph Corey
Martin E Stryjewski

Showing results (51-60 of 194) with videos related to

Pageof 20
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2004
Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged DatabaseVivian H Chu, Christopher H Cabell, Elias Abrutyn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organismsMartin E Stryjewski, Donald R Graham, Samuel E Wilson, et al.
The Journal of Infectious Diseases|October 9, 2007
Expression of antimicrobial peptides in the normal and involved skin of patients with infective cellulitisMartin E Stryjewski, Russell P Hall, Vivian H Chu, et al.
Infection Control and Hospital Epidemiology|March 11, 2005
Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremiaShelby D Reed, Joëlle Y Friedman, John J Engemann, et al.
Expert Review of Anti-Infective Therapy|October 16, 2018
Iclaprim: a differentiated option for the treatment of skin and skin structure infectionsStephanie Noviello, David B Huang, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2005
Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteriaMartin E Stryjewski, William D O'Riordan, William K Lau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2019
Delafloxacin in Acute Bacterial Skin and Skin Structure InfectionsG Ralph Corey, Jamie A McKinnell, Michael J Rybak
Expert Opinion on Pharmacotherapy|March 25, 2015
Oritavancin for acute bacterial skin and skin structure infectionsJulia A Messina, Vance G Fowler, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
Introduction: fusidic acid enters the United StatesRobert C Moellering, G Ralph Corey, M Lindsay Grayson
Current Infectious Disease Reports|July 22, 2004
Issues in the Management of Endocarditis Caused by Resistant Gram-positive OrganismsMartin E. Stryjewski, Vivian H. Chu, Christopher H. Cabell, et al.
Pageof 20

Showing results (51-60 of 194) with videos related to

Sort By:
Pageof 20
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2004
Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged DatabaseVivian H Chu, Christopher H Cabell, Elias Abrutyn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organismsMartin E Stryjewski, Donald R Graham, Samuel E Wilson, et al.
The Journal of Infectious Diseases|October 9, 2007
Expression of antimicrobial peptides in the normal and involved skin of patients with infective cellulitisMartin E Stryjewski, Russell P Hall, Vivian H Chu, et al.
Infection Control and Hospital Epidemiology|March 11, 2005
Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremiaShelby D Reed, Joëlle Y Friedman, John J Engemann, et al.
Expert Review of Anti-Infective Therapy|October 16, 2018
Iclaprim: a differentiated option for the treatment of skin and skin structure infectionsStephanie Noviello, David B Huang, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2005
Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteriaMartin E Stryjewski, William D O'Riordan, William K Lau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2019
Delafloxacin in Acute Bacterial Skin and Skin Structure InfectionsG Ralph Corey, Jamie A McKinnell, Michael J Rybak
Expert Opinion on Pharmacotherapy|March 25, 2015
Oritavancin for acute bacterial skin and skin structure infectionsJulia A Messina, Vance G Fowler, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
Introduction: fusidic acid enters the United StatesRobert C Moellering, G Ralph Corey, M Lindsay Grayson
Current Infectious Disease Reports|July 22, 2004
Issues in the Management of Endocarditis Caused by Resistant Gram-positive OrganismsMartin E. Stryjewski, Vivian H. Chu, Christopher H. Cabell, et al.
Pageof 20